MicroRNA-27b plays a role in pulmonary arterial hypertension by modulating peroxisome proliferator-activated receptor γ dependent Hsp90-eNOS signaling and nitric oxide production
- 1 May 2015
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 460 (2), 469-475
- https://doi.org/10.1016/j.bbrc.2015.03.057
Abstract
No abstract availableKeywords
Funding Information
- 81372520
- 13XD1403200
This publication has 34 references indexed in Scilit:
- miRNA-27b Targets Vascular Endothelial Growth Factor C to Inhibit Tumor Progression and Angiogenesis in Colorectal CancerPLOS ONE, 2013
- MiR-27b targets PPARγ to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cellsOncogene, 2011
- Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in miceCell Research, 2011
- Rosiglitazone Attenuates Chronic Hypoxia–Induced Pulmonary Hypertension in a Mouse ModelAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Dynamic Changes in Lung MicroRNA Profiles During the Development of Pulmonary Hypertension due to Chronic Hypoxia and MonocrotalineArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor γ (PPARγ) mRNA DestabilizationJournal of Biological Chemistry, 2010
- microRNA miR-27b impairs human adipocyte differentiation and targets PPARγBiochemical and Biophysical Research Communications, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- An antiproliferative BMP-2/PPARγ/apoE axis in human and murine SMCs and its role in pulmonary hypertensionJCI Insight, 2008
- The Role of Peroxisome Proliferator-Activated Receptors in Pulmonary Vascular DiseasePPAR Research, 2007